Related Experiment Video
Updated: May 7, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Intravenous tenecteplase in acute ischemic stroke: an updated review
1Division of Cerebrovascular Diseases and Neurological Critical Care, Department of Neurology, The Ohio State University College of Medicine, 395 West 12th Avenue, Suite 766, Columbus, OH, 43215, USA, reza.behrouz@osumc.edu.
Abstract:
Tenecteplase in a genetically engineered variant of alteplase. Although the two have the same mechanism of action, tenecteplase has properties that makes it a seemingly more advantageous thrombolytic. Because of its rapid single-bolus administration, its use is favored over alteplase in the treatment of acute myocardial infarction. Over the past few years, several clinical studies have been conducted to assess the safety, feasibility, and efficacy of tenecteplase in ischemic stroke. In spite of the mixed results of these studies, experimentation with tenecteplase continues in from of clinical trials. In this article, the utility of tenecteplase in ischemic stroke will be discussed.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Venous Thrombosis III: Interprofessional Care
Transient Ischemic Attack l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Stroke: Introduction and Types

